+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1slg | ||||||
---|---|---|---|---|---|---|---|
タイトル | STREPTAVIDIN, PH 5.6, BOUND TO PEPTIDE FCHPQNT | ||||||
![]() |
| ||||||
![]() | COMPLEX(BIOTIN-BINDING PROTEIN/PEPTIDE) / COMPLEX(BIOTIN-BINDING PROTEIN-PEPTIDE) / COMPLEX(BIOTIN-BINDING PROTEIN-PEPTIDE) complex | ||||||
機能・相同性 | ![]() | ||||||
生物種 | ![]() | ||||||
手法 | ![]() | ||||||
![]() | Katz, B.A. | ||||||
![]() | ![]() タイトル: Binding to protein targets of peptidic leads discovered by phage display: crystal structures of streptavidin-bound linear and cyclic peptide ligands containing the HPQ sequence 著者: Katz, B.A. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 80.9 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 62 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 384.8 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 395.6 KB | 表示 | |
XML形式データ | ![]() | 7.8 KB | 表示 | |
CIF形式データ | ![]() | 12.3 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||
単位格子 |
| ||||||||
Atom site foot note | 1: LYS B 134 - PRO B 135 OMEGA = 148.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION | ||||||||
非結晶学的対称性 (NCS) | NCS oper: (Code: given Matrix: (-1, -0.029, -0.004), ベクター: 詳細 | MTRIX THE TRANSFORMATIONS PRESENTED ON MTRIX RECORDS BELOW DESCRIBE NON-CRYSTALLOGRAPHIC RELATIONSHIPS AMONG THE VARIOUS DOMAINS IN THIS ENTRY. APPLYING THE APPROPRIATE MTRIX TRANSFORMATION TO THE RESIDUES LISTED FIRST WILL YIELD APPROXIMATE COORDINATES FOR THE RESIDUES LISTED SECOND. NONCRYSTALLOGRAPHIC TWO-FOLD RELATING PROTOMERS OF THE STREPTAVIDIN TETRAMER APPLIED TO TRANSFORMED TO MTRIX RESIDUES RESIDUES RMSD M1 B 13 .. M 7 D 13 .. P 7 0.845 SYMMETRY THE CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS PRESENTED BELOW GENERATE THE SUBUNITS OF THE POLYMERIC MOLECULE. STREPTAVIDIN IS A TETRAMERIC PROTEIN. THE CRYSTALLOGRAPHIC TRANSFORMATION GIVEN HERE GENERATES THE TETRAMER FROM THE DIMER FOUND IN THE ASYMMETRIC UNIT OF THE CRYSTALS. APPLIED TO RESIDUES: B 13 .. B 133 D 13 .. D 133 M 2 .. M 6 P 1 .. P 6 SYMMETRY1 1 1.000000 0.000000 0.000000 0.00000 SYMMETRY2 1 0.000000 -1.000000 0.000000 0.00000 SYMMETRY3 1 0.000000 0.000000 -1.000000 0.00000 | |
-
要素
#1: タンパク質 | 分子量: 14181.324 Da / 分子数: 2 / 由来タイプ: 天然 / 由来: (天然) ![]() #2: タンパク質・ペプチド | 分子量: 830.864 Da / 分子数: 2 / 由来タイプ: 天然 #3: 水 | ChemComp-HOH / | |
---|
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 2.04 Å3/Da / 溶媒含有率: 39.61 % |
---|---|
結晶化 | pH: 5.6 / 詳細: pH 5.6 |
結晶化 | *PLUS pH: 4 / 手法: 蒸気拡散法, シッティングドロップ法 |
溶液の組成 | *PLUS 濃度: 15 mg/ml / 一般名: peptide |
-データ収集
放射光源 | 波長: 1.5418 |
---|---|
検出器 | タイプ: SIEMENS / 検出器: AREA DETECTOR |
放射 | 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.5418 Å / 相対比: 1 |
反射 | Num. obs: 21587 / Observed criterion σ(I): 3.5 / 冗長度: 4.4 % / Rmerge(I) obs: 0.072 |
反射 | *PLUS 最高解像度: 1.74 Å / 最低解像度: 50 Å / Num. measured all: 94347 / Rmerge(I) obs: 0.072 |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 解像度: 1.76→7.5 Å / σ(F): 1 詳細: CRYST1 CELL AXES CHOSEN TO CORRESPOND TO COORDINATES OF STREPTAVIDIN DEPOSITED BY WEBER ET AL. IN THE PDB (ENTRY 1PTS). THE FOLLOWING ATOMS HAD WEAK DENSITY AND OCCUPANCIES WERE REFINED: B ...詳細: CRYST1 CELL AXES CHOSEN TO CORRESPOND TO COORDINATES OF STREPTAVIDIN DEPOSITED BY WEBER ET AL. IN THE PDB (ENTRY 1PTS). THE FOLLOWING ATOMS HAD WEAK DENSITY AND OCCUPANCIES WERE REFINED: B 13, B 14, B 15 AND (NOT NAME C OR NAME O) D 13, D 14, D 15 AND (NOT NAME C OR NAME O) D 46, D 47, D 48, D 49, D 50, D 51 AND (NOT NAME C OR NAME O) B 46, B 47, B 48, B 49, B 50 AND (NOT NAME C OR NAME O) B 67, B 68 AND (NOT NAME C OR NAME O) B 53 AND (NAME NE OR NAME NH1 OR NAME NH2 OR NAME CZ) B 103 AND (NAME NE OR NAME NH1 OR NAME NH2 OR NAME CZ) D 103 AND (NAME NE OR NAME NH1 OR NAME NH2 OR NAME CZ) D 84 AND (NAME NE OR NAME NH1 OR NAME NH2 OR NAME CZ) B 116 AND (NAME CG OR NAME OR NAME OE1 OR NAME OE2) M 7, P 1, P 2, B 135 M 1 WAS NOT LOCATED OR INCLUDED IN THE MODEL. DISCRETELY DISORDERED SIDE CHAINS WHOSE OCCUPANCIES AND STRUCTURES WERE SIMULTANEOUSLY REFINED WERE B 73, D 73, B 110, D 110, B 22, D 107, D 105. B 22 IS DISORDERED BETWEEN 2 CONFORMATIONS ONE OF WHICH OCCUPIES A SIMILAR REGION OF SPACE AS A TWO-FOLD RELATED B 22. THIS DISORDER CAN NOT BE PROPERLY REFINED WITH X-PLOR. SEVERAL WATERS ARE ON OR NEAR TWO-FOLD AXES, AND CAN NOT BE PROPERLY REFINED WITH X-PLOR. BULK SOLVENT WAS REFINED.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 22 Å2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 1.76→7.5 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: ![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 | *PLUS
|